Back
DHI Group Vs. Nektar Therapeutics Industry Stock Comparison
Buy
53
DHX
DHI Group
Last Price:
$2.86
Seasonality Move:
1.97%
Buy
56
NKTR
Nektar Therapeutics
Last Price:
$24.44
Seasonality Move:
3.38%
Buy
56
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $25.01. The Score for NKTR is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DHX Stock Price Chart
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $25.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight selling pressure.
DHX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.66 | Buy |
Relative Strength Index (14 RSI): | 58.19 | Buy |
Chaikin Money Flow: | 5557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.46 - 3.02) | Buy |
Bollinger Bands (100): | (1.49 - 2.63) | Buy |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.41 | Buy |
Relative Strength Index (14 RSI): | 65.9 | Buy |
Chaikin Money Flow: | -64604 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.5 - 25.8) | Buy |
Bollinger Bands (100): | (7.55 - 17.95) | Buy |
DHX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.06 | Sell |
20-day SMA: | 2.82 | Buy |
50-day SMA: | 2.29 | Buy |
200-day SMA: | 2.02 | Buy |
8-day EMA: | 1.87 | Buy |
20-day EMA: | 0.98 | Buy |
50-day EMA: | 0.44 | Buy |
200-day EMA: | 0.12 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.32 | Buy |
20-day SMA: | 19.57 | Buy |
50-day SMA: | 14.05 | Buy |
200-day SMA: | 14.55 | Buy |
8-day EMA: | 15.41 | Buy |
20-day EMA: | 7.97 | Buy |
50-day EMA: | 3.56 | Buy |
200-day EMA: | 0.94 | Buy |
DHI Group Earnings Growth & DHX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.05 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.86 per share, and an increase next year of $0.01 per share.
DHI Group Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |